A comparative analysis of 23 structures of the amyloidogenic protein transthyretin

Journal of Molecular Biology

Volumn 302, Issue 3, 2000, Pages 649-669

  Hörnberg, Andreas ^a   Eneqvist, Therese ^a   Olofsson, Anders ^a   Lundgren, Erik ^a   Sauer Eriksson, A Elisabeth ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Amyloidosis; Familial amyloidotic polyneuropathy; Structural comparison; Transthyretin; X ray structure

Indexed keywords

AMYLOID P COMPONENT; PLASMA PROTEIN; PREALBUMIN;

AMYLOIDOSIS; ARTICLE; CRYSTAL STRUCTURE; FAMILIAL DISEASE; HUMAN; NEUROLOGIC DISEASE; POLYNEUROPATHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; X RAY CRYSTALLOGRAPHY;

EID: 0034703380     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2000.4078     Document Type: Article

References (86)

1. ICM - A new method for protein modelling and design. Applications to docking and structure prediction from the distorted native conformation
2. Transthyretin amyloidosis
3. Protein-DNA and protein-hormone interactions in prealbumin: A model of the thyroid hormone nuclear receptor
4. Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous β-sheet helix
5. Structure of human plasma prealbumin at 2-5 Å resolution. A preliminary report on the polypeptide chain conformation, quaternary structure and thyroxine binding
6. Structure of prealbumin: Secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8 Å
7. A molecular model of the amyloid fibril
8. Free R value: A novel statistical quantity for assessing the accuracy of crystal structures
9. Crystallography and NMR system: A new software suite for macromolecular structure determination
10. Cross protein structures. I. Insulin fibrils
11. Crystal structure determination at 2.3 Å resolution of human transthyretin-3',5'-dibromo-2',4,4',6-tetrahydroxyaurone complex
12. Amyloidosis
13. The CCP4 suite: Programs for protein crystallography
14. Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro
15. Tabulation of transthyretin (TTR) variants as of 1/1/2000
16. Structure of the Val122Ile variant transthyretin - A cardiomyopathic mutant
17. Characterization of a transthyretin (prealbumin) variant associated with familial amyloidotic polyneuropathy type II (Indiana/Swiss)
18. Accurate bond and angle parameters for X-ray protein structure refinement
19. Unifying features of systemic and cerebral amyloidosis
20. Amyloid deposits and amyloidosis. The β-fibrilloses (first of two parts)
21. Normal transthyretin and synthetic transthyretin fragments form amyloid-like fibrils in vitro
22. Alteration in molecular structure which results in disease: The Met-30 variant of human plasma transthyretin
23. The X-ray crystal structure refinements of normal human transthyretin and the amyloidogenic Val-30 → Met variant to 1.7-Å resolution
24. Structural changes in transthyretin produced by the Ile 84 Ser mutation which result in decreased affinity for retinol-binding protein
25. Protein structure comparison by alignment of distance matrices
26. Analysis of X-ray diffraction patterns from amyloid of biopsied vitreous humor and kidney of transthyretin (TTR) Met30 familial amyloidotic polyneuropathy (FAP) patients: Axially arrayed TTR monomers constitute the protofilament
27. Transthyretin Pro55, a variant associated with early-onset, aggressive, diffuse amyloidosis with cardiac and neurologic involvement
28. Conformation of amino acid side-chains in proteins
29. Improved methods for building protein models in electron density maps and the location of errors in these models
30. Alternative conformations of amyloidogenic proteins govern their behavior
31. Amyloid fibril formation and protein misassembly: A structural quest for insights into amyloid and prion diseases
32. The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways
33. Rational design of potent human transthyretin amyloid disease inhibitors
34. A super position
35. Efficient rebuilding of protein structures
36. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures
37. The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid
38. Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: Implications for wild-type, V30M, and L55P amyloid fibril formation
39. Main-chain bond lengths and bond angles in protein structures
40. The interpretation of protein structures: Estimation of static accessibility
41. TOP: A new method for protein structure comparisons and similarity searches
42. Traitment statistique des erreurs dans la determination des structures cristallines
43. Proteoglycans and the extracellular matrix in amyloidosis
44. Intermolecular disulfide linkages are not required for transthyretin amyloid fibril formation in vitro
45. Transthyretin mutation Leu-55-Pro significantly alters tetramer stability and increases amyloidogenicity
46. Comparison of lethal and non-lethal transthyretin variants and their relationship to amyloid disease
47. Raster3D photorealistic molecular graphics
48. Inhibiting transthyretin fibril formation via protein stabilization
49. Crystallization of the macromolecular complex transthyretin-retinol-binding protein
50. Structure of a complex of two plasma proteins: Transthyretin and retinol-binding protein
51. Refinement of macromolecular structures by the maximum-likelihood method
52. Efficient anisotropic refinement of macromolecular structures using FFT
53. The structure of human retinol-binding protein (RBP) with its carrier protein transthyretin reveals an interaction with the carboxy terminus of RBP
54. Protein subunit interactions and structural integrity of amyloidogenic transthyretins: Evidence from electrospray mass spectrometry
55. Processing of X-ray diffraction data collected in oscillation mode
56. Amyloidosis
57. Inhibiting transthyretin conformational changes that lead to amyloid fibril formation
58. On the binding of Congo red by amyloid
59. A review of light polarization and fluorescence microscopic methods for amyloid
60. The amyloidogenic potential of transthyretin variants correlates with their tendency to aggregate in solution
61. Conformation of polypeptides and proteins
62. A simple method for making reproducible fibre loops for protein cryocrystallography
63. Tertiary structures of amyloidogenic and non-amyloidogenic transthyretin variants: New model for amyloid fibril formation
64. The evolution of gene expression, structure and function of transthyretin
65. Crystallization and preliminary X-ray diffraction studies of Leu55Pro variant transthyretin
66. 55 → Pro transthyretin variant reveals a possible pathway for transthyretin polymerization into amyloid fibrils
67. Amyloidosis
68. Amyloidosis
69. Amyloid P component
70. X-ray crystal structure of the Ala-109 → Thr variant of human transthyretin which produces euthyroid hyperthyroxinemia
71. Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients
72. The crystal structure of transthyretin from chicken
73. Common core structure of amyloid fibrils by synchrotron X-ray diffraction
74. Amyloidosis
75. Structure of Met30 variant of transthyretin and its amyloidogenic implications
76. Modifications of transthyretin in amyloid fibrils: Analysis of amyloid from homozygous and heterozygous individuals with the Met30 mutation
77. A new mutant transthyretin (Arg 10) associated with familial amyloid polyneuropathy
78. Biochemical and molecular genetic characterization of a new variant prealbumin associated with hereditary amyloidosis
79. Fibril in senile systemic amyloidosis is derived from normal transthyretin
80. Crystal structure of rat transthyretin at 2.5 Å resolution: First report on a unique tetrameric structure
81. Mechanism of molecular recognition: Structural aspects of 3,3'-diiodo-L-thyronine binding to human serum transthyretin
82. Structural aspects of inotropic bipyridine binding: Crystal structure determination to 1.9 Å of the human serum transthyretin-milrinone complex
83. Structures of human transthyretin complexed with thyroxine at 2.0 Å resolution and 3',5'-dinitro-N-acetyl-L-thyronine at 2.2 Å resolution
84. Crystal structure of the transthyretin-retinoic-acid complex